Human hepatocellular carcinoma (HCC) generally develops on the background of chronic inflammation, fibrosis or liver cirrhosis.The risk of cancer development from chronic hepatitis or cirrhosis varies with the degree of fibrosis. the Transforming Growth Factor Beta1 cytokine is strongly linked to tissue fibrosis and can be implicated in tumor development. We studied the synthesis and expression of TGFbeta 1 in the tumour lesions chemically induced in Fisher 344 genetic susceptible rat strains compared to Brown Norway resistant rat strains. TGFbeta1 related cell signal was abolished in susceptible strain; this event was in relationship to the alteration of the activity NADPH oxidase hepatic isoforrms, suggesting a role of pro-oxidant processes in the different susceptibility to hepatocarcinogenesis. TGFbeta1 expression and concomitant loss of its signal pathway in nodules of susceptible strain make the altered hepatocyte clones able to overcome the TGFbeta1 antiproliferative effects, thereby allowing a tumor growth advantage.

Lipid oxidation and fibrogenesis in cancer progression

BIASI, Fiorella
2009-01-01

Abstract

Human hepatocellular carcinoma (HCC) generally develops on the background of chronic inflammation, fibrosis or liver cirrhosis.The risk of cancer development from chronic hepatitis or cirrhosis varies with the degree of fibrosis. the Transforming Growth Factor Beta1 cytokine is strongly linked to tissue fibrosis and can be implicated in tumor development. We studied the synthesis and expression of TGFbeta 1 in the tumour lesions chemically induced in Fisher 344 genetic susceptible rat strains compared to Brown Norway resistant rat strains. TGFbeta1 related cell signal was abolished in susceptible strain; this event was in relationship to the alteration of the activity NADPH oxidase hepatic isoforrms, suggesting a role of pro-oxidant processes in the different susceptibility to hepatocarcinogenesis. TGFbeta1 expression and concomitant loss of its signal pathway in nodules of susceptible strain make the altered hepatocyte clones able to overcome the TGFbeta1 antiproliferative effects, thereby allowing a tumor growth advantage.
2009
1st Congress of Fatty Liver and Metabolic Syndrome - From Basic Science to the Clinical Praxis
Budapest
12–14 Novembre 2009
3
579
579
hepatocarcinogenesis; NAPHoxidase; genetic predisposition; lipid oxidation; fibrosis
Biasi F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/77131
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact